A View from the IE&C GroupRod Hill

Creating and Sustaining Cross-Faculty Collaboration

27 July 2010

Open Innovation Models of Collaboration

26 2522

28

53

39

30

35

2724

17

21

31

18 18

14

$12 $13 $13$15

$17$19

$21$23

$26

$30$32 $33

$39 $39

$43

$54

0

10

20

30

40

50

60

0

5

10

15

20

25

30

35

40

45

50

$55

New Drug Approvals (NMEs) PhRMA Member R&D Spending

New

Dru

g App

rova

ls (N

MEs)

Pha

rma

R&

D ($

billi

ons)

92 93 94 95 96 97 98 99 00 01 02 03 04 05 06 07

“Open innovation is a paradigm that assumes that firms can and should use external ideas as well as internal ideas, and internal and external paths to market, as the firms look to advance their technology”

Henry Chesbrough, Center for Open Innovation at UC Berkeley, 2004

Malcolm Skingle, GSK: Berrill & Co, US FDA

Partnering at Monash

Multidisciplinary research and "Open Innovation" are at the heart of the major partnerships and alliances developed at Monash

That is, the partnering of cross-Faculty capability and know how from industry, other research partners and the University in an open and collaborative way to tackle the really big issues that confront business and society.

Obstacles to Engagement across Organisational & Discipline Boundaries

• Discomfort with unfamiliar ‘vocabulary’ and culture for different discipline areas, organisational entities and geography

• Personal “ownership” of particular relationships by individuals – perceived dilution and loss of control

• Assumption that the “size of the cake” is constant – smaller share

• Lack of time to devote to developing the engagement relationship

• Lack of ability to develop and communicate a shared vision and value proposition that delivers to joint needs

• Project initiation and management is more complex – leading to delays

• University reward structures not closely aligned with ‘Impact delivery’

• ERA has a focus on the individual researcher

Major IE&C Actions to Promote Collaboration

• Independent ‘Broker/Facilitator’ of the initial dialog between parties and, perhaps, project leadership

• Development of a framework for Strategic Alliances

• Implementation of a Key Account Management system, UniSTAR to (i) log BDM activities, and (ii) provide a platform for customer relationship management

• Organisation point for CRCs, CoEs, relationship with CSIRO, Monash Business Breakfasts

• Lead for the SE Melbourne Innovation Precinct

Key strengths provided by the co-location of:

1. Australia’s largest comprehensive research intensive University (with key international connections);

2. Largest CSIRO site (700 staff 1100 by 2012), with a focus on materials science & eng, and medical & health technologies;

3. Australia’s only Synchrotron ($230M), with a strong focus on materials characterisation and medical imaging;

4. Australia’s prestigious Teaching Hospital – Monash Medical Centre – and proposed new Hospital (700 beds);

5. Victoria’s premier hub for light manufacturing and business incubation;

6. The $45M NCRIS Nano-fabrication Facility

Clayton Innovation Precinct

Industry Partnerships: Aid Research Translation & Technology Adoption Greater Impact

Contract Research

Research Collaborations

Alliance Management

Major Partnership Models Take Time to Work

Chair

Graduates

Guest lectures

Education

Workforce development

Scholarships

Internships

Commercial relationship

UniversityProcurement

Strategic and collaborative researchacross priorityR&D areas

Research

ARC Linkage Grants

Chair

Case Studies of Major Relationships

• CSIRO New Horizons, Green Chemistry FuturesEngineering + Science

• ISCRR TAC-Worksafe Victoria Medicine + MUARC

• IBM Internships, professional developmentIT + BusEco + eResearch

• Agilent/Varian Imaging, Biospectroscopy, ManufacturingMedicine + Engineering +

Science• GE Medical imaging

Medicine + Science• GSK Production facility, Drug discovery, Mftg

PPS + Engineering + Medicine

Case Study – CSIRO in 2000

Cammeray Waters, near Woodend, VIC